HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Marrow transplantation for pancytopenia in dyskeratosis congenita.

Abstract
A 33-year-old man with dyskeratosis congenita received a marrow transplant to treat severe pancytopenia. The graft was successful-, but the patient developed severe acute graft-versus-host-disease grade IV and died 51 days postgrafting. - The outcome of transplantation in dyskeratosis congenita is compared to that in Fanconi's anaemia due to the resemblance of both diseases in some aspects.
AuthorsH K Mahmoud, U W Schaefer, C G Schmidt, R Becher, G F Götz, H J Richter
JournalBlut (Blut) Vol. 51 Issue 1 Pg. 57-60 (Jul 1985) ISSN: 0006-5242 [Print] Germany
PMID3893572 (Publication Type: Case Reports, Journal Article)
Topics
  • Adult
  • Bone Marrow Transplantation
  • Humans
  • Male
  • Pancytopenia (complications, therapy)
  • Pigmentation Disorders (complications, genetics)
  • Skin Diseases (complications, genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: